Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nihon Chouzai Co's revenue for the
three
months ended in Sep. 2025 was $659 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2025 was $1,311 Mil.
Nihon Chouzai Co's Revenue per Share for the
three
months ended in Sep. 2025 was $3,469.40.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $6,617.54.
Warning Sign:
Nihon Chouzai Co Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Nihon Chouzai Co was -18.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 6.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Nihon Chouzai Co's highest 3-Year average Revenue per Share Growth Rate was 16.60% per year. The lowest was 1.70% per year. And the median was 8.95% per year.
Nihon Chouzai Co (OTCPK:NHCZF) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Nihon Chouzai Co Revenue Related Terms
Nihon Chouzai Co Revenue Historical Data
* Premium members only.
The historical data trend for Nihon Chouzai Co's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Nihon Chouzai Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Chouzai Co Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nihon Chouzai Co's Revenue distribution charts can be found below:
* The bar in red indicates where Nihon Chouzai Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,311 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Chouzai Co (NHCZF) has a Revenue of $1,311 Mil as of Sep. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Nihon Chouzai Co and its competitors.
Is Nihon Chouzai Co's Revenue too high?
Nihon Chouzai Co's current Revenue is $1,311 Mil. Overall, Nihon Chouzai Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Nihon Chouzai Co's Revenue compare to competitors?
Nihon Chouzai Co's Revenue of $1,311 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Nihon Chouzai Co and its competitors. Nihon Chouzai Co's current Revenue is $1,311 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Chouzai Co stock overvalued right now?
Nihon Chouzai Co (NHCZF) has a current Revenue of $1,311 Mil. The stock's GF Value™ is $6.38, compared to a current price of $16.02 — trading 151.1% above its estimated fair value. The current Revenue is $1,311 Mil. Nihon Chouzai Co's overall GF Score™ is 9/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Nihon Chouzai Co (NHCZF), the current Revenue is $1,311 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Chouzai Co (NHCZF) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Chouzai Co stock appears to be overvalued.
The current stock price of $16.02 is trading 151.1% above its estimated GF Value™ of $6.38.
Key valuation signals for NHCZF:
Revenue: $1,311 Mil
GF Value™: $6.38 vs. price of $16.02 (151.1% above fair value)
No single metric tells the full story. See the NHCZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Chouzai Co Ltd operates in the pharmaceutical industry. The company is organized into segments: Pharmacy, Pharmaceutical Manufacturing and Sales, and Healthcare Staffing Services and operates mainly from Japan. Through its operating segments, the firm manages a chain of pharmacies nationwide, manufactures and sells generic drugs, and provides staffing services that are specialized in pharmacy.
9GF Score
Get the complete analysis for NHCZF
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHCZF has been successfully added to your 
